End-of-day quote
Other stock markets
|
||
- CAD | - |
15/05 | Transcript : MediPharm Labs Corp., Q1 2024 Earnings Call, May 15, 2024 | |
15/05 | MediPharm Labs Q1 Gross Profit, Rise | MT |
Sales 2024 * | 42M 30.77M 2.56B | Sales 2025 * | 54.91M 40.23M 3.35B | Capitalization | 32.34M 23.69M 1.97B |
---|---|---|---|---|---|
Net income 2024 * | -9M -6.59M -549M | Net income 2025 * | -2M -1.47M -122M | EV / Sales 2024 * | 0.77 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.59 x |
P/E ratio 2024 * |
-4
x | P/E ratio 2025 * |
-16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.53% |
Latest transcript on Medipharm Labs Corp
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Greg Hunter
DFI | Director of Finance/CFO | - | 08/21/08 |
Keith Strachan
PSD | President | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 01/23/01 |
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Shelley Martin
BRD | Director/Board Member | - | 22/20/22 |
1st Jan change | Capi. | |
---|---|---|
+43.31% | 6.19B | |
-16.99% | 4.48B | |
+6.39% | 3.29B | |
-13.10% | 3.12B | |
-4.17% | 2.5B | |
+45.47% | 1.94B | |
-9.11% | 1.68B | |
-2.09% | 1.64B | |
-12.50% | 1.56B |